Prof. Dr. Alexander M.M. Eggermont, MD, PhD
Utrecht University, Netherlands
Board of the Comprehensive Cancer Center Munich (CCCM), Technical University Munich & Ludwig Maximiliaan University Munich, Munich, Germany.
Chief Scientific Officer Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands Prof Clinical &Translational Immunotherapy, University Medical Center Utrecht, Netherlands.
Coordinator Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany & Strategic Advisor @ DKFZ-NCT Heidelberg for National Center for Tumors Program, Germany.
Past Director General, Gustave Roussy Cancer Campus Grand Paris, France (2010-2019) & Emeritus Professor Oncology, University Paris-Saclay, France (2012-2021).
Emeritus Professor International Networking Cancer Research, ErasmusMC, Rotterdam, NL Emeritus Professor Surgical Oncology Erasmus University Rotterdam, NL.
Honorary Professor Surgical Oncology, Catholic University Leuven, Belgium.
Fellow of USA NIH-NCI Surgery Branch (Steve Rosenberg) (85-86) PhD1987 TumorImmunology.
International (current & past) scientific societal positions
- President European Academy of Cancer Sciences (2010-2019), Executive board (2019-now)
- President Cancer Core Europe 2014-2019
- ECCO President European CanCer Organization 2009-2011
- EORTC President 2006-2009, Exec Board 1998-2012, Chairman Melanoma Group(1994-2000)
- ASCO: Board of Directors of ASCO (2008-2010; Surgery Chair) and JCO Editorial Board
- AACR: Deputy Editor of Clinical Cancer Research 2001-2009
- ESMO: Executive Board: 2014-2018
- CRUK: Board of Trustees/Strategic Research Committee 2016-2019
- DFG: Wissenschaftsrat, Germany: 2017-2020
- DKH (Deutsche Krebshilfe) (Since 2007-Now) President International Jury CCC-Program
- European Journal of Cancer: Editor-in-Chief since 01-01-2011
Professional awards (selection): Joseph Maisin Chair in Oncology at Catholic University of Louvain in Belgium (2001); ASCO Statesman Award (2010); Michiel Van Vloten Award of the Dutch Surgical Society (2016); John Wayne Award of Clinical Research of Society Surgical Oncology (2018); Doctorate Honoris Causa (University Essen, Germany) (2018); Honorary Chair KAZIOR (Kazakh Institute of Oncology and Radiotherapy)(2019); Deutsche Krebshilfe Cancer Award (2019)
Specialties & Scientific Output: Clinical: immunotherapy, melanoma, sarcoma,drug development. Basic/Translational: tumor immunology, animal models. Scientific Output: >1000 publications; 36 PhD theses @ ErasmusMC: H-index/citations: 113, >61000 citations (Web of Science), HI:115, >66000 (Scopus); HI:128, >80000 (Research Gate); HI:134, >93000 citations (Google Scholar)
Societal Awards: Légion d’Honneur, France (2015)
Prof. Dr. Caroline Robert, MD, PhD
Gustave Roussy Cancer Campus, France
Caroline Robert, M.D., Ph.D. did her MD training at the Paris V University Medicine School, France and completed a research fellowship at Harvard, Brigham & Women’s hospital, Boston MA, USA in Cancer Immunology and Immunotherapy. She is currently Head of the Dermatology Service at Gustave Roussy Cancer Campus and director of the Melanoma Research Unit at INSERM 981 Paris-Saclay University. She is full Professor of Dermatology and responsible for teaching Dermatology and Dermato-Oncology in Paris-Saclay University Medicine School. Her main interests are clinical and translational Research on Melanoma and non-melanoma skin cancers involving immunotherapy and targeted therapy. She is national and international coordinator of many clinical trials from phase I to III dedicated to patients with melanoma and other skin cancers. Her research work focuses on the involvement of the control of mRNA translation in resistance to cancer therapies. The objectives are the identification of new predictive biomarkers as well as the development of new therapies to delay therapeutic resistance. She has authored more than 500 articles in peer-reviewed scientific journals. She is a member of the editorial board of Cell and New England Journal of Medicine Evidence.
She and past-president the Melanoma group of the EORTC and is board member of several European and US cooperative groups: EADO, ESMO, EADV, ASCO and AACR.
She has received several awards and prizes including, Estela Medrano Award for the Society for Melanoma Research in 2018, the ESMO Woman Award in 2020. She was elected as a corresponding member of the French National Academy of Medicine in 2019. She was made Knight of the French Legion of Honor in 2014 and Officer of the French National Order of Merit in 2021 and received the Line Renaud Prize from the Medical Research Foundation and the Turpin Prize from the Academy of Sciences in 2024.
